Dokumendiregister | Terviseamet |
Viit | 8.1-2/24/2973-1 |
Registreeritud | 19.03.2024 |
Sünkroonitud | 26.03.2024 |
Liik | Sissetulev dokument |
Funktsioon | 8.1 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
Sari | 8.1-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
Toimik | 8.1-2/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | ECDC respiratory viruses |
Saabumis/saatmisviis | ECDC respiratory viruses |
Vastutaja | Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond) |
Originaal | Ava uues aknas |
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
ECDC NORMAL
To: Operational Contact Points for Influenza and COVID-19 (Microbiology), Western Balkan and Türkiye Contact Points for Operations (Influenza and COVID-19 microbiology)
Cc: National Focal Points for Viral Respiratory Diseases, National Coordinators, Western Balkan and Türkiye Observer National Focal Points for Viral Respiratory Diseases and National Correspondents
Dear Colleagues,
This is a kind reminder to send your views on AURORAE virus characterisation and technical support activities (see message below).
Please coordinate within your institute, so that one set of answers is sent.
Best wishes,
The ECDC and AURORAE consortium
|
From: ECDC respiratory viruses
Sent: Tuesday, March 12, 2024 11:41 AM
Cc: ECDC Info <[email protected]>
Subject: FOR ACTION to OCPs for influenza (microbiology) and SARS-CoV-2 - ECDC AURORAE: Please help us improve our influenza virus and SARS-CoV-2 services! – a short feedback questionnaire
To: Operational Contact Points for Influenza and COVID-19 (Microbiology), Western Balkan and Türkiye Contact Points for Operations (Influenza and COVID-19 microbiology)
Cc: National Focal Points for Viral Respiratory Diseases, National Coordinators, Western Balkan and Türkiye Observer National Focal Points for Viral Respiratory Diseases and National Correspondents
Dear Colleagues,
AURORAE provides technology support for implementation, optimization, and validation of influenza virus and SARS-CoV-2 tests.
AURORAE also provides handbooks and protocols for influenza virus and SARS-CoV-2.
We'd like to gain insight into how you use the services provided by AURORAE.
Please take approximately 10 - 15 minutes to complete this questionnaire at https://ec.europa.eu/eusurvey/runner/AURORAEuserfeedback2024
and share your feedback by end of business 22 March 2024.
Your feedback is most appreciated and will be used for improving the AURORAE laboratory services.
Best wishes,
The ECDC and AURORAE consortium
|
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.